Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.01.2023 | Case report

Asenapine/olanzapine

Various toxicities: 17 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Matsuzaki H, et al. Treatment Continuation of Asenapine or Olanzapine in Japanese Schizophrenia Patients: A Propensity Score Matched Study. Neuropsychiatric Disease and Treatment 17: 3655-3661, Jan 2021. Available from: URL: http://doi.org/10.2147/NDT.S343840 Matsuzaki H, et al. Treatment Continuation of Asenapine or Olanzapine in Japanese Schizophrenia Patients: A Propensity Score Matched Study. Neuropsychiatric Disease and Treatment 17: 3655-3661, Jan 2021. Available from: URL: http://​doi.​org/​10.​2147/​NDT.​S343840
Metadaten
Titel
Asenapine/olanzapine
Various toxicities: 17 case reports
Publikationsdatum
01.01.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-30374-0

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Antineoplastics

Case report

Pazopanib

Case report

Tozinameran